These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23280210)

  • 21. Editorial: Omega-3 fatty acids and cardiovascular outcomes: an update.
    Calder PC; Deckelbaum RJ
    Curr Opin Clin Nutr Metab Care; 2019 Mar; 22(2):97-102. PubMed ID: 30585800
    [No Abstract]   [Full Text] [Related]  

  • 22. [Omega-3 fatty acids--both food and medicine].
    Retterstøl K
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2258. PubMed ID: 23736186
    [No Abstract]   [Full Text] [Related]  

  • 23. Indications for Omega-3 Long Chain Polyunsaturated Fatty Acid in the Prevention and Treatment of Cardiovascular Disease.
    Nestel P; Clifton P; Colquhoun D; Noakes M; Mori TA; Sullivan D; Thomas B
    Heart Lung Circ; 2015 Aug; 24(8):769-79. PubMed ID: 25936871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined supplementation of vitamin B12 and omega-3 fatty acids across two generations improves cardiometabolic variables in rats.
    Khaire A; Rathod R; Randhir K; Kale A; Joshi S
    Food Funct; 2016 Sep; 7(9):3910-9. PubMed ID: 27528436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of omega-3 polyunsaturated fatty acids in cardiovascular health.
    Barrett SJ
    Altern Ther Health Med; 2013; 19 Suppl 1():26-30. PubMed ID: 23981464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rebuttal to Aung et al, "Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals".
    von Schacky C
    Altern Ther Health Med; 2018 Mar; 24(2):8-9. PubMed ID: 29859508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of omega-3 fatty acids in cardiovascular disease.
    Saremi A; Arora R
    Am J Ther; 2009; 16(5):421-36. PubMed ID: 19092647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association.
    Kris-Etherton PM; Harris WS; Appel LJ;
    Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):151-2. PubMed ID: 12588750
    [No Abstract]   [Full Text] [Related]  

  • 29. Current evidence and future perspectives of omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease.
    Rizos EC; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 706(1-3):1-3. PubMed ID: 23499683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 Fatty Acid Supplementation in the Primary and Secondary Prevention of Cardiovascular Events: NEW INSIGHTS.
    O'Connell TF; Trivax J; Franklin BA
    J Cardiopulm Rehabil Prev; 2021 May; 41(3):137-140. PubMed ID: 33907071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 fatty acids: recommendations for therapeutics and prevention.
    Hutchins H; Vega CP
    MedGenMed; 2005 Oct; 7(4):18. PubMed ID: 16614640
    [No Abstract]   [Full Text] [Related]  

  • 32. Focus on omega-3 PUFAs in heart failure.
    Aalbers J
    Cardiovasc J Afr; 2012 Jul; 23(6):345. PubMed ID: 22836158
    [No Abstract]   [Full Text] [Related]  

  • 33. Reply to the editor.
    Costanzo S; Di Castelnuovo A; Iacoviello L
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):992-3. PubMed ID: 24041166
    [No Abstract]   [Full Text] [Related]  

  • 34. Have the heart for fish oil?
    Johns Hopkins Med Lett Health After 50; 2008 Sep; 20(7):1-2. PubMed ID: 18822526
    [No Abstract]   [Full Text] [Related]  

  • 35. The big ones that got away: omega-3 meta-analysis flawed by excluding the biggest fish oil trials.
    DiNicolantonio JJ; O'Keefe JH; Lavie CJ
    Arch Intern Med; 2012 Oct; 172(18):1427; author reply 1427-8. PubMed ID: 23045179
    [No Abstract]   [Full Text] [Related]  

  • 36. Omega-3 oil: fish or pills?
    Consum Rep; 2003 Jul; 68(7):30-2. PubMed ID: 12841165
    [No Abstract]   [Full Text] [Related]  

  • 37. N-3 fatty acids: priority for post-myocardial infarction clinical trials.
    Grundy SM
    Circulation; 2003 Apr; 107(14):1834-6. PubMed ID: 12695281
    [No Abstract]   [Full Text] [Related]  

  • 38. Omega-3 Fatty Acids and Cardiovascular Disease.
    Rogers TS; Seehusen DA
    Am Fam Physician; 2018 May; 97(9):562-564. PubMed ID: 29763262
    [No Abstract]   [Full Text] [Related]  

  • 39. The cardiovascular benefits of indiscriminate supplementation of omega-3 fatty acids; meta-analysis and decision-making approach.
    Leshno M; Goldbourt U; Pinchuk I; Lichtenberg D
    Int J Food Sci Nutr; 2018 Aug; 69(5):549-556. PubMed ID: 29171335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ω-3 Fatty acids and lutein + zeaxanthin supplementation for the prevention of cardiovascular disease.
    Rizos EC; Ntzani EE
    JAMA Intern Med; 2014 May; 174(5):771-2. PubMed ID: 24638082
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.